Bovine lactoferrin suppresses high-fat diet induced obesity and modulates gut microbiota in C57BL/6J mice

Journal of Functional Foods

Volumn 22, Issue , 2016, Pages 189-200

  Sun, Jing ^a   Ren, Fazheng ^a   Xiong, Ling ^a   Zhao, Liang ^a   Guo, Huiyuan ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bifidobacterium spp; Bovine lactoferrin; Gut microbiota; Inflammation; Mice; Obesity

Indexed keywords

EID: 84962302572     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.01.022     Document Type: Article

References (56)

1. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:979-984.
2. Bleau C., Karelis A.D., St-Pierre D.H., Lamontagne L. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes. Diabetes/Metabolism Research and Reviews 2015, 31:545-561.
3. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
4. Chen P., Zhang Q., Dang H., Liu X., Tian F., Zhao J., Chen Y., Zhang H., Chen W. Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin. Nutrition (Burbank, Los Angeles County, Calif.) 2014, 30:1061-1068.
5. Crouch S.P.M., Slater K.J., Fletcher J. Regulation of cytokine release from mononuclear-cells by the iron-binding protein lactoferrin. Blood 1992, 80:235-240.
6. de La Serre C.B., Ellis C.L., Lee J., Hartman A.L., Rutledge J.C., Raybould H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American Journal of Physiology. Gastrointestinal and Liver Physiology 2010, 299:G440-G448.
7. Di Gioia D., Aloisio I., Mazzola G., Biavati B. Bifidobacteria: Their impact on gut microbiota composition and their applications as probiotics in infants. Applied Microbiology and Biotechnology 2014, 98:563-577.
8. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M.J., Magness S., Jobin C., Lund P.K. High-fat diet: Bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 2010, 5.
9. Ding S., Lund P.K. Role of intestinal inflammation as an early event in obesity and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care 2011, 14:328.
10. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., de Vos W.M., Cani P.D. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:9066-9071.
11. Fernandez-Real J.M., Garcia-Fuentes E., Moreno-Navarrete J.M., Murri-Pierri M., Garrido-Sanchez L., Ricart W., Tinahones F. Fat overload induces changes in circulating lactoferrin that are associated with postprandial lipemia and oxidative stress in severely obese subjects. Obesity 2010, 18:482-488.
12. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocrine Reviews 2002, 23:824-854.
13. Garcia-Montoya I.A., Siqueiros Cendon T., Arevalo-Gallegos S., Rascon-Cruz Q. Lactoferrin a multiple bioactive protein: An overview. Biochimica Et Biophysica Acta-General Subjects 2012, 1820:226-236.
14. Gauffin Cano P., Santacruz A., Trejo F.M., Sanz Y. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity 2013, 21:2310-2321.
15. Guo H.Y., Jiang L., Ibrahim S.A., Zhang L., Zhang H., Zhang M., Ren F.Z. Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats. The Journal of Nutrition 2009, 139:958-964.
16. Hirotani Y., Ikeda K., Kato R., Myotoku M., Umeda T., Ijiri Y., Tanaka K. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 2008, 128:1363-1368.
17. Ilich J.Z., Kelly O.J., Kim Y., Spicer M.T. Low-grade chronic inflammation perpetuated by modern diet as a promoter of obesity and osteoporosis. Arhiv Za Higijenu Rada I Toksikologiju-Archives of Industrial Hygiene and Toxicology 2014, 65:139-148.
18. Jenssen H., Hancock R.E.W. Antimicrobial properties of lactoferrin. Biochimie 2009, 91:19-29.
19. Kim B.-S., Song M., Kim H. The anti-obesity effect of Ephedra sinica through modulation of gut microbiota in obese Korean women. Journal of Ethnopharmacology 2014, 152:532-539.
20. Kim K.-A., Gu W., Lee I.-A., Joh E.-H., Kim D.-H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE 2012, 7.
21. Koch C.E., Lowe C., Pretz D., Steger J., Williams L.M., Tups A. High-fat diet induces leptin resistance in leptin-deficient mice. Journal of Neuroendocrinology 2014, 26:58-67.
22. Kondo S., Xiao J., Satoh T., Odamaki T., Takahashi S., Sugahara H., Yaeshima T., Iwatsuki K., Kamei A., Abe K. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience, Biotechnology, and Biochemistry 2010, 74:1656-1661.
23. Le Drean G., Haure-Mirande V., Ferrier L., Bonnet C., Hulin P., de Coppet P., Segain J.P. Visceral adipose tissue and leptin increase colonic epithelial tight junction permeability via a RhoA-ROCK-dependent pathway. Faseb Journal 2014, 28:1059-1070.
24. Legrand D. Lactoferrin, a key molecule in immune and inflammatory processes. Biochemistry and Cell Biology-Biochimie Et Biologie Cellulaire 2012, 90:252-268.
25. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11070-11075.
26. Lord G.M., Matarese G., Howard L.K., Baker R.J., Bloom S.R., Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901.
27. Martin S.S., Qasim A., Reilly M.P. Leptin resistance - A possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 2008, 52:1201-1210.
28. Matter K., Aijaz S., Tsapara A., Balda M.S. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Current Opinion in Cell Biology 2005, 17:453-458.
29. Moreno-Navarrete J.M., Ortega F.J., Ricart W., Fernandez-Real J.M. Lactoferrin increases (172Thr)AMPK phosphorylation and insulin-induced (p473Ser)AKT while impairing adipocyte differentiation. International Journal of Obesity 2009, 33:991-1000.
30. Moreno-Navarrete J.M., Ortega F., Sabater M., Ricart W., Fernandez-Real J.M. Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes. Journal of Nutritional Biochemistry 2011, 22:1143-1149.
31. Mori A. Agent useful for preventing obesity, acne, dermatitis and in foodstuff, comprises milk origin protein e.g. lactoferrin 2010, In: Upwell Kk.
32. Muller G., Ertl J., Gerl M., Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. Journal of Biological Chemistry 1997, 272:10585-10593.
33. Nam M.S., Cho M.C., Bae H.C., Yoon D.Y. Effects of lactoferrin on adipogenesis in 3T3-L1 cells and obesity mice. Biochemistry and Cell Biology-Biochimie Et Biologie Cellulaire 2006, 84:399.
34. Nam S.Y., Lee E.J., Kim K.R., Cha B.S., Song Y.D., Lim S.K., Lee H.C., Huh K.D. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. International Journal of Obesity 1997, 21:355-359.
35. Nave H., Mueller G., Siegmund B., Jacobs R., Stroh T., Schueler U., Hopfe M., Behrendt P., Buchenauer T., Pabst R., Brabant G. Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: A novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008, 149:3370-3378.
36. Neyrinck A.M., Van Hee V.F., Bindels L.B., De Backer F., Cani P.D., Delzenne N.M. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: Potential implication of the gut microbiota. British Journal of Nutrition 2013, 109:802-809.
37. Ono T., Murakoshi M., Suzuki N., Iida N., Ohdera M., Iigo M., Yoshida T., Sugiyama K., Nishino H. Potent anti-obesity effect of enteric-coated lactoferrin: Decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. British Journal of Nutrition 2010, 104:1688-1695.
38. Paturi G., Butts C.A., Bentley-Hewitt K.L., Hedderley D., Stoklosinski H., Ansell J. Differential effects of probiotics, prebiotics, and synbiotics on gut microbiota and gene expression in rats. Journal of Functional Foods 2015, 13:204-213.
39. Pierce A., Legrand D., Mazurier J. Lactoferrin: A multifunctional protein. M S-Medecine Sciences 2009, 25:361-369.
40. Rajwani A., Ezzat V., Smith J., Yuldasheva N.Y., Duncan E.R., Gage M., Cubbon R.M., Kahn M.B., Imrie H., Abbas A., Viswambharan H., Aziz A., Sukumar P., Vidal-Puig A., Sethi J.K., Xuan S.H., Shah A.M., Grant P.J., Porter K.E., Kearney M.T., Wheatcroft S.B. Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes 2012, 61:915-924.
41. Ramos-Romero S., Molinar-Toribio E., Gomez L., Perez-Jimenez J., Casado M., Clapes P., Pina B., Lluis Torres J. Effect of D-fagomine on excreted enterobacteria and weight gain in rats fed a high-fat high-sucrose diet. Obesity 2014, 22:976-979.
42. Roberts A.K., Chierici R., Sawatzki G., Hill M.J., Volpato S., Vigi V. Supplementation of an adapted formula with bovine lactoferrin. 1. Effect on the infant fecal flora. Acta Paediatrica 1992, 81:119-124.
43. Scavuzzi B.M., Miglioranza L.H.D., Henrique F.C., Paroschi T.P., Lozovoy M.A.B., Simao A.N.C., Dichi I. The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks. Expert Opinion on Therapeutic Targets 2015, 19:1127-1138.
44. Shan C.Y., Yang J.H., Kong Y., Wang X.Y., Zheng M.Y., Xu Y.G., Wang Y., Ren H.Z., Chang B.C., Chen L.M. Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats. Journal of Endocrinology 2013, 218:255-262.
45. Shi J., Finckenberg P., Martonen E., Ahlroos-Lehmus A., Pilvi T.K., Korpela R., Mervaala E.M. Metabolic effects of lactoferrin during energy restriction and weight regain in diet-induced obese mice. Journal of Functional Foods 2012, 4:66-78.
46. Teixeira T.F.S., Grzeskowiak L.M., Salminen S., Laitinen K., Bressan J., Gouveia Peluzio M.D.C. Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women. Clinical Nutrition 2013, 32:1017-1022.
47. Teraguchi S., Ozawa K., Yasuda S., Shin K., Fukuwatari Y., Shimamura S. The bacteriostatic effects of orally-administered bovine lactoferrin on intestinal Enterobacteriaceae of SPF mice fed bovine-milk. Bioscience, Biotechnology, and Biochemistry 1994, 58:482-487.
48. Tomita M., Wakabayashi H., Shin K., Yamauchi K., Yaeshima T., Iwatsuki K. Twenty-five years of research on bovine lactoferrin applications. Biochimie 2009, 91:52-57.
49. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
50. Verdam F.J., Fuentes S., de Jonge C., Zoetendal E.G., Erbil R., Greve J.W., Buurman W.A., de Vos W.M., Rensen S.S. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity 2013, 21:E607-E615.
51. Wakabayashi H., Yamauchi K., Takase M. Lactoferrin research, technology and applications. International Dairy Journal 2006, 16:1241-1251.
52. Wang Z., Xiao G., Yao Y., Guo S., Lu K., Sheng Z. The role of bifidobacteria thermal injury in rats. Journal of Trauma-Injury Infection and Critical Care 2006, 61:650-657.
53. Xiao S., Fei N., Pang X., Shen J., Wang L., Zhang B., Zhang M., Zhang X., Zhang C., Li M., Sun L., Xue Z., Wang J., Feng J., Yan F., Zhao N., Liu J., Long W., Zhao L. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiology Ecology 2014, 87:357-367.
54. Yagi M., Suzuki N., Takayama T., Arisue M., Kodama T., Yoda Y., Numasaki H., Otsuka K., Ito K. Lactoferrin suppress the adipogenic differentiation of MC3T3-G2/PA6 cells. Journal of Oral Science 2008, 50:419-425.
55. Zaenker K.S. Use of a recombinant human lactoferrin or human lactoferrin e.g. for preparing a medicament or dietary supplement for regulating adiponectin levels in blood or in supplementary balanced diet, and preventing/treating e.g. obesity 2009, In: Vczs Venture Capital Zentralschweiz Ag.
56. Zhang C., Zhang M., Pang X., Zhao Y., Wang L., Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. Isme Journal 2012, 6:1848-1857.